Vireo Growth (VREOF) Current Assets (2020 - 2026)

Vireo Growth (VREOF) reported Current Assets of $258.3 million for Q1 2026, up 13.07% on a YoY basis from $228.4 million in Q1 2025, and down 15.34% sequentially from $305.1 million in Q4 2025.

Vireo Growth (VREOF) Current Assets (2020 - 2026) Analysis & Trends

Vireo Growth (VREOF) has 7 years of Current Assets data on file, last reported at $258.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Current Assets rose 13.07% year-over-year to $258.3 million; the trailing twelve-month figure through Mar 2026 stood at $258.3 million (up 13.07% YoY), and the FY2025 full-year result was $305.1 million, up 32.44% from the prior year.
  • Current Assets declined to $258.3 million in Q1 2026, from $305.1 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $312.8 million in Q2 2025 to a low of $38.8 million in Q1 2022.
  • A 5-year average of $164.4 million and a median of $147.2 million in 2024 frame the typical range for Current Assets.
  • Across the five-year window, Current Assets sank 33.89% in 2022 and soared 218.55% in 2023, its largest moves.
  • Tracing VREOF's Current Assets over 5 years: stood at $46.7 million in 2022, then soared by 218.55% to $148.9 million in 2023, then surged by 54.77% to $230.4 million in 2024, then jumped by 32.44% to $305.1 million in 2025, then slipped by 15.34% to $258.3 million in 2026.
  • Business Quant data shows VREOF's Current Assets at $258.3 million in Q1 2026, $305.1 million in Q4 2025, and $308.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 6.05 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.71 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 6.47 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 19.71 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 2.87 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 53.60 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 10.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.44 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 3.58 Bn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 258.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 258.30 Mn
Dec 31, 2025 305.10 Mn
Sep 30, 2025 307.96 Mn
Jun 30, 2025 312.79 Mn
Mar 31, 2025 228.43 Mn
Dec 31, 2024 230.37 Mn
Sep 30, 2024 143.96 Mn
Jun 30, 2024 148.63 Mn
Mar 31, 2024 147.18 Mn
Dec 31, 2023 148.85 Mn
Sep 30, 2023 135.11 Mn
Jun 30, 2023 126.37 Mn
Mar 31, 2023 115.56 Mn
Dec 31, 2022 46.73 Mn
Sep 30, 2022 53.86 Mn
Jun 30, 2022 46.39 Mn
Mar 31, 2022 38.75 Mn
Dec 31, 2021 41.64 Mn
Sep 30, 2021 44.75 Mn
Jun 30, 2021 41.96 Mn